Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 2
1992 1
1993 3
1994 1
1999 1
2001 1
2002 4
2003 1
2004 1
2005 1
2007 1
2008 1
2010 1
2011 1
2012 1
2016 1
2019 2
2020 1
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

27 results
Results by year
Filters applied: . Clear all
Page 1
Tissue-specific MR contrast agents.
Weinmann HJ, Ebert W, Misselwitz B, Schmitt-Willich H. Weinmann HJ, et al. Among authors: schmitt willich h. Eur J Radiol. 2003 Apr;46(1):33-44. doi: 10.1016/s0720-048x(02)00332-7. Eur J Radiol. 2003. PMID: 12648800 Review.
PI-2620 Lead Optimization Highlights the Importance of Off-Target Assays to Develop a PET Tracer for the Detection of Pathological Aggregated Tau in Alzheimer's Disease and Other Tauopathies.
Kroth H, Oden F, Molette J, Schieferstein H, Gabellieri E, Mueller A, Berndt M, Sreenivasachary N, Serra AM, Capotosti F, Schmitt-Willich H, Hickman D, Pfeifer A, Dinkelborg L, Stephens A. Kroth H, et al. Among authors: schmitt willich h. J Med Chem. 2021 Sep 9;64(17):12808-12830. doi: 10.1021/acs.jmedchem.1c00861. Epub 2021 Aug 29. J Med Chem. 2021. PMID: 34455780
The Characterization of 18F-hGTS13 for Molecular Imaging of xC- Transporter Activity with PET.
Beinat C, Gowrishankar G, Shen B, Alam IS, Robinson E, Haywood T, Patel CB, Azevedo EC, Castillo JB, Ilovich O, Koglin N, Schmitt-Willich H, Berndt M, Mueller A, Zerna M, Srinivasan A, Gambhir SS. Beinat C, et al. Among authors: schmitt willich h. J Nucl Med. 2019 Dec;60(12):1812-1817. doi: 10.2967/jnumed.119.225870. Epub 2019 Jun 6. J Nucl Med. 2019. PMID: 31171595 Free article.
Discovery of 2-(4-(2-fluoroethoxy)piperidin-1-yl)-9-methyl-9H-pyrrolo[2,3-b:4,5-c']dipyridine ([18F]PI-2014) as PET tracer for the detection of pathological aggregated tau in Alzheimer's disease and other tauopathies.
Gabellieri E, Capotosti F, Molette J, Sreenivasachary N, Mueller A, Berndt M, Schieferstein H, Juergens T, Varisco Y, Oden F, Schmitt-Willich H, Hickman D, Dinkelborg L, Stephens A, Pfeifer A, Kroth H. Gabellieri E, et al. Among authors: schmitt willich h. Eur J Med Chem. 2020 Oct 15;204:112615. doi: 10.1016/j.ejmech.2020.112615. Epub 2020 Jul 15. Eur J Med Chem. 2020. PMID: 32771872
Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer's disease and other tauopathies.
Kroth H, Oden F, Molette J, Schieferstein H, Capotosti F, Mueller A, Berndt M, Schmitt-Willich H, Darmency V, Gabellieri E, Boudou C, Juergens T, Varisco Y, Vokali E, Hickman DT, Tamagnan G, Pfeifer A, Dinkelborg L, Muhs A, Stephens A. Kroth H, et al. Among authors: schmitt willich h. Eur J Nucl Med Mol Imaging. 2019 Sep;46(10):2178-2189. doi: 10.1007/s00259-019-04397-2. Epub 2019 Jul 1. Eur J Nucl Med Mol Imaging. 2019. PMID: 31264169 Free PMC article.
Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies.
Mittra ES, Koglin N, Mosci C, Kumar M, Hoehne A, Keu KV, Iagaru AH, Mueller A, Berndt M, Bullich S, Friebe M, Schmitt-Willich H, Gekeler V, Fels LM, Bacher-Stier C, Moon DH, Chin FT, Stephens AW, Dinkelborg LM, Gambhir SS. Mittra ES, et al. Among authors: schmitt willich h. PLoS One. 2016 Feb 18;11(2):e0148628. doi: 10.1371/journal.pone.0148628. eCollection 2016. PLoS One. 2016. PMID: 26890637 Free PMC article.
Preclinical characterization of a novel class of 18F-labeled PET tracers for amyloid-β.
Brockschnieder D, Schmitt-Willich H, Heinrich T, Varrone A, Gulyás B, Toth M, Andersson J, Boemer U, Krause S, Friebe M, Dinkelborg L, Halldin C, Dyrks T. Brockschnieder D, et al. Among authors: schmitt willich h. J Nucl Med. 2012 Nov;53(11):1794-801. doi: 10.2967/jnumed.112.104810. Epub 2012 Sep 24. J Nucl Med. 2012. PMID: 23008501 Free article.
Comparative studies on the efficacy of MRI contrast agents in MRA.
Weinmann HJ, Bauer H, Ebert W, Frenzel T, Radüchel B, Platzek J, Schmitt-Willich H. Weinmann HJ, et al. Among authors: schmitt willich h. Acad Radiol. 2002 May;9 Suppl 1:S135-6. doi: 10.1016/s1076-6332(03)80419-1. Acad Radiol. 2002. PMID: 12019849 No abstract available.
27 results